These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Tumour-vasculature development via endothelial-to-mesenchymal transition after radiotherapy controls CD44v6 Choi SH; Kim AR; Nam JK; Kim JM; Kim JY; Seo HR; Lee HJ; Cho J; Lee YJ Nat Commun; 2018 Nov; 9(1):5108. PubMed ID: 30504836 [TBL] [Abstract][Full Text] [Related]
6. Understanding the role of the tumour vasculature in the transport of drugs to solid cancer tumours. Wijeratne NS; Hoo KA Cell Prolif; 2007 Jun; 40(3):283-301. PubMed ID: 17531075 [TBL] [Abstract][Full Text] [Related]
7. In vivo efficacy of HSV-TK transcriptionally targeted to the tumour vasculature is augmented by combination with cytotoxic chemotherapy. Mavria G; Harrington KJ; Marshall CJ; Porter CD J Gene Med; 2005 Mar; 7(3):263-75. PubMed ID: 15543524 [TBL] [Abstract][Full Text] [Related]
8. iPSC-derived cancer stem cells provide a model of tumor vasculature. Prieto-Vila M; Yan T; Calle AS; Nair N; Hurley L; Kasai T; Kakuta H; Masuda J; Murakami H; Mizutani A; Seno M Am J Cancer Res; 2016; 6(9):1906-1921. PubMed ID: 27725898 [TBL] [Abstract][Full Text] [Related]
9. The changing paradigm of tumour response to irradiation. Hill RP Br J Radiol; 2017 Jan; 90(1069):20160474. PubMed ID: 27416998 [TBL] [Abstract][Full Text] [Related]
10. Melanoma tumour vasculature heterogeneity: from mice models to human. Pautu V; Mellinger A; Resnier P; Lepeltier E; Martin L; Boussemart L; Letournel F; Passirani C; Clere N J Cancer Res Clin Oncol; 2019 Mar; 145(3):589-597. PubMed ID: 30547320 [TBL] [Abstract][Full Text] [Related]
11. Pericytes in Metastasis. Pieterse Z; Sinha D; Kaur P Adv Exp Med Biol; 2019; 1147():125-135. PubMed ID: 31147875 [TBL] [Abstract][Full Text] [Related]
12. The Tumour Vasculature as a Target to Modulate Leucocyte Trafficking. Zhao Y; Ting KK; Coleman P; Qi Y; Chen J; Vadas M; Gamble J Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33917287 [TBL] [Abstract][Full Text] [Related]
14. CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours. Vega FM; Colmenero-Repiso A; Gómez-Muñoz MA; Rodríguez-Prieto I; Aguilar-Morante D; Ramírez G; Márquez C; Cabello R; Pardal R EBioMedicine; 2019 Nov; 49():82-95. PubMed ID: 31685444 [TBL] [Abstract][Full Text] [Related]
15. HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression. Philip B; Ito K; Moreno-Sánchez R; Ralph SJ Carcinogenesis; 2013 Aug; 34(8):1699-707. PubMed ID: 23740838 [TBL] [Abstract][Full Text] [Related]
17. Cancer therapeutic potential of combinatorial immuno- and vasomodulatory interventions. Hatzikirou H; Alfonso JC; Mühle S; Stern C; Weiss S; Meyer-Hermann M J R Soc Interface; 2015 Nov; 12(112):. PubMed ID: 26510827 [TBL] [Abstract][Full Text] [Related]
18. Cancer stem cells and epithelial ovarian cancer. Dyall S; Gayther SA; Dafou D J Oncol; 2010; 2010():105269. PubMed ID: 21318146 [TBL] [Abstract][Full Text] [Related]
19. Stem cells and cancer of the stomach and intestine. Vries RG; Huch M; Clevers H Mol Oncol; 2010 Oct; 4(5):373-84. PubMed ID: 20598659 [TBL] [Abstract][Full Text] [Related]
20. Cancer stem cells may contribute to the difficulty in treating cancer. Iseghohi SO Genes Dis; 2016 Mar; 3(1):7-10. PubMed ID: 30258875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]